Europe Bovine Respiratory Disease Treatment Market by Type of Treatment (Anti-Infectious Agents (antibiotics and sulfas), Anti-Parasiticides, Bronchodilators, Oral Rehydration Fluids, Non-Steroidal Anti-Inflammatories, and Mucolytic), and by Region - Industry Analysis, Size, Share, Growth, Trends, and Forecasts (2016–2021)

Europe Bovine Respiratory Disease Treatment Market by Type of Treatment (Anti-Infectious Agents (antibiotics and sulfas), Anti-Parasiticides, Bronchodilators, Oral Rehydration Fluids, Non-Steroidal Anti-Inflammatories, and Mucolytic), and by Region - Industry Analysis, Size, Share, Growth, Trends, and Forecasts (2016–2021)

ID: 910 | Pages: 142 | October 2016 | Region: Europe


The Europe Bovine Respiratory Disease Treatment Market has been estimated at USD 6.13 million in 2016 and is projected to reach USD 15.56 million by 2021, at a CAGR of 20.5% during the forecast period from 2016 to 2021. There is a huge influence of bovine respiratory disease (BRD), diarrhoea, arthritis and otitis on the economically significant parameters of mortality, hot carcass weight (HCW), carcass quality, fat cover and meat colour which produces problem for the cattle production.

BRD is a complex multi-factorial disease that involves an interaction between several factors. In the current scenario body temperature has been used to determine whether treatment should be done or not. Body temperature is such an important diagnostic test that many feedlots will treat animals based upon an undifferentiated fever. 

A combination of disease organisms is usually accountable for the respiratory infection and illness, but other factors also affect the animal’s health. Environmental factors, particularly transport, have been associated with BRD; weather has always been implicated in the occurrence of the disease. It has been concluded that stressful events, and others like calving or an overenthusiastic introduction to high grain rations, may precipitate cases of BRD.

The Europe bovine respiratory disease treatment market has been segmented on the basis of type of treatment into anti-infectious agents, anti-parasiticides, bronchodilators, oral rehydration fluids, non-steroidal anti-inflammatories, and mucolytic. Anti-infectious can be further sub-segmented into antibiotics and sulfas. Antibiotics and anti-inflammatory drugs are now being used for combination treatment and expected to improve the success rate of the treatment. Geographically Europe market is segmented into France, Italy, Spain, Germany and UK.

The major companies dominating this market by their products and services are Zoetis Inc., Merck & Co. Inc., Bayer Corporation, Eli Lilly & Co., Merial S.A.S, Boehringer Ingelheim Vetmedica, Novartis Animal Health, Vibrac S.A, Ceva Sante Animale and Vétoquinol S.A.

1. Introduction                                                 

                1.1 Market Definition                                    

                1.2 Study Deliverables                                  

                1.3 Base Currency, Base Year and Forecast Periods                                           

                1.4 General Study Assumptions                                

2. Research Methodology                                                           

                2.1 Introduction                                              

                2.2 Research Phases                                      

                                2.2.1 Secondary Research                            

                                2.2.2 Primary Research                 

                                2.2.3 Econometric Modelling                     

                                2.2.4 Expert Validation                  

                2.3 Analysis Design                                         

                2.4 Study Timeline                                          

3. Overview                                                      

                3.1 Executive Summary                                

                3.2 Key Inferences                                         

                3.3 New Developments                                

4. Drivers, Restraints, Opportunities, and Challenges Analysis (DROC)                                                      

                4.1 Market Drivers                                          

                4.2 Market Restraints                                    

                4.3 Key Challenges                                         

                4.4 Current Opportunities in the Market                               

5. Market Segmentation                                                              

                5.1 By Type of Treatment                                            

                                5.1.1 Anti-Infectious Agents                       

                                                5.1.1.1 Antibiotics           

                                                5.1.1.2 Sulfas    

                                5.1.2 Anti-Parasiticides                 

                                5.1.3 Bronchodilators                    

                                5.1.4 Oral Rehydration Fluids                     

                                5.1.5 Non-Steroidal Anti-Inflammatories               

                                5.1.6 Mucolytics                              

6. Geographical Analysis                                                              

                                6.1 Introduction                              

                                6.2 U.K                

                                6.3 Spain                             

                                6.4 Germany                     

                                6.5 Italy                               

                                6.6 France                          

7. Strategic Analysis                                                       

                7.1 PESTLE analysis                                         

                                7.1.1 Political                     

                                7.1.2 Economic                 

                                7.1.3 Social                         

                                7.1.4 Technological                         

                                7.1.5 Legal                          

                                7.1.6 Environmental                      

                7.2 Porter’s Five analysis                                              

                                7.2.1 Bargaining Power of Suppliers                        

                                7.2.2 Bargaining Power of Consumers                    

                                7.2.3 Threat of New Entrants                     

                                7.2.4 Threat of Substitute Products and Services               

                                7.2.5 Competitive Rivalry within the Industry                      

8. Market Leaders' Analysis                                                        

                8.1 Zoetis Inc.                                   

                                8.1.1 Overview                

                                8.1.2 Product Analysis                   

                                8.1.3 Strategic Evaluation and Operations                            

                                8.1.4 Financial analysis                  

                                8.1.5 Legal issues                            

                                8.1.6 Recent Developments                       

                                8.1.7 SWOT analysis                       

                                8.1.8 Analyst View                          

                8.2 Merck & Co. Inc.                                       

                8.3 Bayer Corporation                                   

                8.4 Eli Lilly & Co.                                              

                8.5 Merial S.A.S                               

                8.6 Boehringer Ingelheim Vetmedica                                     

                8.7 Novartis Animal Health                                          

                8.8 Vibrac S.A                                   

                8.9 Ceva Sante Animale                                

                8.10 Vétoquinol S.A.                                      

9. Competitive Landscape                                                           

                9.1 Market share analysis                                            

                9.2 Merger and Acquisition Analysis                                        

                9.3 Agreements, collaborations and Joint Ventures                                          

                9.4 New Product Launches                                          

10. Expert Opinions                                                        

                10.1 Market Outlook                                     

                10.2 Investment Opportunities                                 

Appendix                                                           

                a) List of Tables                                

                b) List of Figures                                              

  • Regional and country-level analysis and forecasts of the study market; providing Insights on the major countries/regions in which this industry is blooming and to also identify the regions that are still untapped
  • Segment-level analysis in terms of technology, component, and type along with market size forecasts and estimations to detect key areas of industry growth in detail
  • Identification of key drivers, restraints, opportunities, and challenges (DROC) in the market and their impact on shifting market dynamics
  • Study of the effect of exogenous and endogenous factors that affect the global market; which includes broadly demographic, economics, and political, among other macro-environmental factors presented in an extensive PESTLE Analysis
  • Study the micro environment factors that determine the overall profitability of an Industry, using Porter’s five forces analysis for analysing the level of competition and business strategy development
  • A comprehensive list of key market players along with their product portfolio, current strategic interests, key financial information, legal issues, SWOT analysis and analyst overview to study and sustain the market environment
  • Competitive landscape analysis listing out the mergers, acquisitions, collaborations in the field along with new product launches, comparative financial studies and recent developments in the market by the major companies
  • An executive summary, abridging the entire report in such a way that decision-making personnel can rapidly become acquainted with background information, concise analysis and main conclusions
  • Expertly devised analyst overview along with Investment opportunities to provide both individuals and organizations a strong financial foothold in the market
TitlePriceAdd To Cart
  1. Europe Bovine Respiratory Disease Treatment Market By Region, From 2016-2021 (USD Million)
  2. Europe Bovine Respiratory Disease Treatment Market By Type of Treatment, From 2016-2021 (USD Million)
  3. Europe Anti-Infectious Agents Market By Region, From 2016-2021 (USD Million)
  4. Europe Bovine Respiratory Disease Treatment Market By Anti-Infectious Agents, From 2016-2021 (USD Million)
  5. Europe Antibiotics Market By Region, From 2016-2021 (USD Million)
  6. Europe Sulfas Market By Region, From 2016-2021 (USD Million)
  7. Europe Anti-Parasiticides Market By Region, From 2016-2021 (USD Million)
  8. Europe Bronchodilators Market By Region, From 2016-2021 (USD Million)
  9. Europe Oral Rehydration Fluids Market By Region, From 2016-2021 (USD Million)
  10. Europe Non-Steroidal Anti-Inflammatories Market By Region, From 2016-2021 (USD Million)
  11. Europe Mucolytic Market By Region, From 2016-2021 (USD Million)
  12. U.K Bovine Respiratory Disease Treatment Market By Type of Treatment, From 2016-2021 (USD Million)
  13. U.K Bovine Respiratory Disease Treatment Market By Anti-Infectious Agents, From 2016-2021 (USD Million)
  14. Spain Bovine Respiratory Disease Treatment Market By Type of Treatment, From 2016-2021 (USD Million)
  15. Spain Bovine Respiratory Disease Treatment Market By Anti-Infectious Agents, From 2016-2021 (USD Million)
  16. Germany Bovine Respiratory Disease Treatment Market By Type of Treatment, From 2016-2021 (USD Million)
  17. Germany Bovine Respiratory Disease Treatment Market By Anti-Infectious Agents, From 2016-2021 (USD Million)
  18. Italy Bovine Respiratory Disease Treatment Market By Type of Treatment, From 2016-2021 (USD Million)
  19. Italy Bovine Respiratory Disease Treatment Market By Anti-Infectious Agents, From 2016-2021 (USD Million)
  20. France Bovine Respiratory Disease Treatment Market By Type of Treatment, From 2016-2021 (USD Million)
  21. France Bovine Respiratory Disease Treatment Market By Anti-Infectious Agents, From 2016-2021 (USD Million)
Middle East and Africa Companion Animal Health Care Market by Product type – (Feed Additives, Pharmaceuticals, and Vaccines) and by Region - Industry Analysis, Size, Share, Growth, Trends, and Forecasts (2016–20...
Latin America Companion Animal Health Care Market by Product type – (Feed Additives, Pharmaceuticals, and Vaccines) and by Region - Industry Analysis, Size, Share, Growth, Trends, and Forecasts (2016–2021) ...
Asia-Pacific Companion Animal Health Care Market by Product type – (Feed Additives, Pharmaceuticals, and Vaccines) and by Region - Industry Analysis, Size, Share, Growth, Trends, and Forecasts (2016–2021) ...
Europe Companion Animal Health Care Market by Product type – (Feed Additives, Pharmaceuticals, and Vaccines) and by Region - Industry Analysis, Size, Share, Growth, Trends, and Forecasts (2016–2021) ...
North America Companion Animal Health Care Market by Product type – (Feed Additives, Pharmaceuticals, and Vaccines) and by Region - Industry Analysis, Size, Share, Growth, Trends, and Forecasts (2016–2021) ...
Companion Animal Health Care Market by Product type – (Feed Additives, Pharmaceuticals, and Vaccines) and by Region - Global Industry Analysis, Size, Share, Growth, Trends, and Forecasts (2016–2021) ...
Middle-East and Africa Bovine Respiratory Disease Treatment Market by Type of Treatment (Anti-Infectious Agents (antibiotics and sulfas), Anti-Parasiticides, Bronchodilators, Oral Rehydration Fluids, Non-Steroidal A...
Latin America Bovine Respiratory Disease Treatment Market by Type of Treatment (Anti-Infectious Agents (antibiotics and sulfas), Anti-Parasiticides, Bronchodilators, Oral Rehydration Fluids, Non-Steroidal Anti-Infla...
Asia-Pacific Bovine Respiratory Disease Treatment Market by Type of Treatment (Anti-Infectious Agents (antibiotics and sulfas), Anti-Parasiticides, Bronchodilators, Oral Rehydration Fluids, Non-Steroidal Anti-Inflam...
Europe Bovine Respiratory Disease Treatment Market by Type of Treatment (Anti-Infectious Agents (antibiotics and sulfas), Anti-Parasiticides, Bronchodilators, Oral Rehydration Fluids, Non-Steroidal Anti-Inflammatori...
North America Bovine Respiratory Disease Treatment Market by Type of Treatment (Anti-Infectious Agents (antibiotics and sulfas), Anti-Parasiticides, Bronchodilators, Oral Rehydration Fluids, Non-Steroidal Anti-Infla...
Bovine Respiratory Disease Treatment Market by Type of Treatment (Anti-Infectious Agents (Antibiotics and Sulfas), Anti-Parasiticides, Bronchodilators, Oral Rehydration Fluids, Non-Steroidal Anti-Inflammatories, and...

"We Think Through Different Layers, We Work Across Different Verticals."

Market Data Forecast, Inc.
502, Kakatiya's Empire,
Jubilee Gardens, Hyderabad,
Telangana, India.
+1-888-702-9626 (U.S. TOLL FREE)
contact@marketdataforecast.com


Subscribe To Our News Letter

Or follow us on social platform

© 2017 Market Data Forecast
All Rights Reserved.